Friday 6 November 2026
Export VCYT’s income statement to Excel — free account
Veracyte, Inc.
VCYT Healthcare Diagnostics & Research
Veracyte, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $517.1 million, up 16.0% from fiscal 2024.
- Revenue
- +15.1%
- EPS
- +62.5%
- Free cash flow
- −9.63%
Quarter to September 2026, against a year earlier
24.14
0.14
+0.58%
Follow VCYT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
5.34% | 6.93% | 8.77% | 9.43% | |
Piotroski F-Score |
8 | 8 | 8 | 7 | |
| 4.90% | 6.40% | 8.09% | 8.63% | ||
ROIC |
4.03% | 5.35% | 7.32% | 4.33% | |
Return on Tangible Assets |
14.72% | 18.01% | 21.44% | 31.05% | |
Average Days of Receivables |
31.52 | 33.76 | 35.19 | 35.63 | |
Free Cash Flow per Share |
1.61 | 1.95 | 2.08 | 2.01 | |
Free Cash Flow |
126.63 | 155.34 | 165.99 | 161.95 | |
Capital Expenditures |
(9.68) | (10.82) | (12.39) | (11.93) | |
| Other line items | |||||
Cash ROIC |
7.35% | 8.71% | 8.86% | 11.30% | |
Accounts Receivable Turnover |
11.34 | 10.43 | 10.70 | 11.12 | |
Accounts Payable Turnover |
23.38 | 13.93 | 16.33 | 21.42 | |
Inventory Turnover |
7.31 | 6.90 | 6.67 | 0.00 | |
Average Days of Payables |
10.84 | 16.00 | 18.43 | 21.74 | |
Days of Inventory on Hand |
48.50 | 49.61 | 52.03 | 0.00 | |
Tax Rate |
(0.03) | (0.03) | (0.01) | 0.07 | |
Research and Development Expense of Revenue |
13.69% | 14.80% | 16.62% | 18.83% | |
Selling, General and Administrative Expense of Revenue |
40.79% | 37.57% | 35.88% | 35.72% | |
Share Based Compensation of Revenue |
8.43% | 8.38% | 8.63% | 8.89% | |
Operating CF/Net income |
2.05 | 1.89 | 1.56 | 1.37 | |
Depreciation/Fixed assets |
0.82 | 0.82 | 0.83 | 0.00 | |
Capex/Depreciation |
(0.53) | (0.59) | (0.68) | 0.00 | |
Revenue per Share |
6.58 | 6.81 | 7.03 | 7.23 | |
Operating CF per Share |
1.73 | 2.09 | 2.23 | 2.16 | |
Capex per Share |
(0.12) | (0.14) | (0.15) | (0.15) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026